CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Total	10% Series A Cumulative Perpetual Preferred Stock	Preferred Stock	Preferred Stock 10% Series A Cumulative Perpetual Preferred Stock	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital 10% Series A Cumulative Perpetual Preferred Stock	Accumulated (Deficit)	Treasury Stock
Balance at Dec. 31, 2019	$ (23.2)							$ (23.2)
Balance, shares at Dec. 31, 2019					7,300,000
Net loss	(24.0)							(24.0)
Stock issued	4.0	$ 28.2				$ 4.0	$ 28.2
Stock issued, shares				1,200,000	507,143
Opening deferred tax liabilities under reverse recapitalization	(6.2)							(6.2)
Equity infusion from reverse recapitalization, net of transaction costs	175.7					175.7
Equity infusion from reverse recapitalization, net of transaction costs, shares					21,911,359
Shares issued upon settlement of equity-linked incentive plan	3.1					3.1
Shares issued upon settlement of equity-linked incentive plan, shares					300,000
Disgorgement of short swing profits	1.6					1.6
Share based compensation	3.6					3.6
Share based compensation, share					390,000
Repurchases of common stock	(5.9)								$ (5.9)
Repurchases of common stock, shares					(390,000)
Balance at Dec. 31, 2020	156.9					216.2		(53.4)	(5.9)
Balance, shares at Dec. 31, 2020			1,200,000		30,018,502
Net loss	(20.8)							(20.8)
Dividends on preferred stock	(2.6)							(2.6)
Share based compensation	1.2					1.2
Warrants exchanged into common stock					2,279,874
Issuance of restricted stock units to employees					65,000
Balance at Dec. 31, 2021	$ 134.7					$ 217.4		$ (76.8)	$ (5.9)
Balance, shares at Dec. 31, 2021			1,200,000		32,363,376